Correction: Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.

Correction: Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4373841?pdf=render

Similar Items

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes.
by: Marika Pane, et al.
Published: (2015-01-01)

Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.
by: Marika Pane, et al.
Published: (2014-01-01)

Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
by: Elena Stacy Mazzone, et al.
Published: (2013-01-01)

Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy.
by: Elena Stacy Mazzone, et al.
Published: (2013-01-01)

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
by: Elena Stacy Mazzone, et al.
Published: (2013-01-01)

Predicting the loss of ambulation in Duchenne muscular dystrophy
by: Edmar Zanoteli
Published: (2014-01-01)

Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
by: PLOS ONE Staff
Published: (2019-01-01)

Epilepsy in Boys with Duchenne Muscular Dystrophy
by: M Etemadifar, et al.
Published: (2004-06-01)

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
by: Claudia Brogna, et al.
Published: (2019-01-01)

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
by: Karin J. Naarding, et al.
Published: (2021-06-01)

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
by: Claudia Brogna, et al.
Published: (2019-01-01)

Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)

Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy
by: Shu Zhang, et al.
Published: (2021-04-01)

Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989-05-01)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021-06-01)

Celiac disease in a boy with duchenne muscular dystrophy: A double jeopardy!
by: Indar K Sharawat, et al.
Published: (2020-01-01)

Feasibility, Safety, and Efficacy of Myoblast Transfer Therapy on Duchenne Muscular Dystrophy Boys
by: Peter K. Law, et al.
Published: (1992-03-01)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
by: Rebecca Ronsley, et al.
Published: (2020-12-01)

Bioelectrical impedance vector analysis and phase angle in boys with Duchenne muscular dystrophy
by: Karina M. Vermeulen, et al.
Published: (2019-04-01)

Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy.
by: Eugenio Mercuri, et al.
Published: (2016-01-01)

Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study
by: Jansen Merel, et al.
Published: (2010-08-01)

Correction: Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study
by: The Staff
Published: (2014-01-01)

Genetic Correction of Duchenne Muscular Dystrophy using Engineered Nucleases
by: Ousterout, David Gerard
Published: (2014)

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
by: Marika Pane, et al.
Published: (2018-01-01)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Simon Guiraud, et al.
Published: (2019-01-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015-01-01)

Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-06-01)

Language Delay in Duchenne’s Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Mortality cost of Duchenne muscular dystrophy
by: Erik Landfeldt, et al.
Published: (2017-04-01)

Brain Function in Duchenne Muscular Dystrophy
by: J. Gordon Millichap
Published: (2002-02-01)

Nutritional Challenges in Duchenne Muscular Dystrophy
by: Simona Salera, et al.
Published: (2017-06-01)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017-02-01)

Early Development in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1990-07-01)

Molecular analysis of Duchenne muscular dystrophy
by: Smith, T. J.
Published: (1988)

Antisense therapies for Duchenne muscular dystrophy
by: Rabinowitz, Adam Howard
Published: (2007)

Genetic studies in Duchenne muscular dystrophy
by: Hodgson, Shirley V.
Published: (1987)